Authors


Scott A. Soefje, PharmD

Latest:

Neulasta Onpro: A Coup de Grâce?

With the rapid decline in average sales price of reference pegfilgrastim products due to biosimilar competition, health care institutions and payers may grapple with coverage of Neulasta Onpro.



Alexa N. Fiffick, DO, MBS, MSCP

Latest:

Closing Thoughts: Evolving Treatment Paradigms in Menopause Management

Panelists express their gratitude for the informative discussion and share their final thoughts on the evolving landscape of menopause management and the potential impact of new therapies on improving patient outcomes.


Mark Stephens, MD

Latest:

Mobile Health Clinic: Lessons Learned Building Partnerships Across Health Systems

Establishing mobile health clinics in rural settings requires collaboration across health systems by aligning missions, building infrastructure to support research, and demonstrating proof of concept.


Vannessa Harrison, DrPH

Latest:

Hospital Discharge Diagnosis Position: Impact on Adult Pneumonia Burden Estimates

Disease burden estimates of pneumonia-associated hospitalizations are more sensitive when including pneumonia coded in any diagnosis field vs in only the first discharge diagnosis field.


Edward Juhn, MD, MBA, MPH

Latest:

Incentivizing Data Sharing Among Health Plans, Hospitals, and Providers to Improve Quality

Health plans can gain efficiencies and improve quality by connecting to health information networks and incentivizing hospital and provider participation as part of pay-for-performance programs.


Lucy Tu, AB

Latest:

Financial Crossroads of Care: Physicians’ Struggle and Patient Outcomes

In 2024, physicians face significant financial challenges due to declining Medicare reimbursement rates and high student loan interest rates, which will impact health care delivery and access.


Allison L. Cipriani, MD

Latest:

Statin Prescribing Patterns in Patient-Centered Medical Home Patients With NAFLD

In this study, authors assessed the proportion of patients with nonalcoholic fatty liver disease (NAFLD) receiving prescriptions for statins in primary care.


Stella K. Kang, MD, MSc

Latest:

When Does Nonadherence Indicate a Deviation From Patient-Centered Care?

The authors suggest that assessment of patient-centered care may be improved by flagging probable discordance between a patient’s preferences and their treatment care plan.


Gregory B. Russell, MS

Latest:

Primary Care Referrals to Nephrology in Patients With Advanced Kidney Disease

Primary care physicians did not refer the majority of patients with severe nephropathy to specialists; nonreferred patients had fewer comorbidities and might be better kidney transplant candidates.


Jacob E. Kurlander, MD, MS

Latest:

Interest in and Concerns About Telehealth Among Adults Aged 50 to 80 Years

In this survey of adults aged 50 to 80 years, sociodemographic factors, as well as experience with video chat, were associated with interest in and concerns about telehealth video visits.


Brian P. Mulherin, MD

Latest:

Background and Causes of Iron Deficiency Anemia

Panelists discuss how chronic kidney disease leads to iron deficiency anemia through a complex interplay of impaired iron absorption, increased hepcidin production driven by inflammatory cytokines, and reduced erythropoietin synthesis, resulting in both functional and absolute iron deficiency alongside diminished red blood cell production.


Chiao-Li Chan, MSW

Latest:

Evaluating Alternative Methods of Comparing Antihypertensive Treatment Intensity

Medication dose captures modification of hypertension treatment intensity more precisely than medication count, and this measure should be preferred in studies that aim to improve hypertension management.


Chau Truong, MPH

Latest:

Evaluation of a Collaborative Model Between Managed Care and Affordable Housing on Acute Care Costs

A collaborative service model between a managed care organization and an affordable housing provider reduced acute care use and costs.


Dolly Sharma, PhD

Latest:

Cost of Home vs Clinic Administration of Paclitaxel in Metastatic Breast Cancer

Home administration of oral paclitaxel and encequidar is associated with potential cost savings for payers compared with clinic administration of intravenous chemotherapy in metastatic breast cancer patients.


Amiee Kang, MPH

Latest:

Journey to Anticoagulant Access Following Payer Rejection of Apixaban

Formulary restrictions can create treatment barriers for patients with atrial fibrillation, including unnecessary delays in treatment and prescription abandonment, with vulnerable populations at greater risk.


Jai Seth, MSc

Latest:

Leveraging Patient Activation to Improve Kidney Health in High-Risk Patients

Frequency of patient-provider conversations and patient activation are the 2 most significant predictors of a high-risk patient’s behaviors to prevent kidney disease.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo